Skip to main navigation Skip to search Skip to main content

AN OPEN RANDOMIZED MULTICENTER STUDY OF THE SAFETY,TOLERABILITY AND IMMUNOGENICITY OF FROZEN MMRV GIVEN CONCOMITANTLY VERSUS NONCONCOMITANTLY WITH OTHER PEDIATICS VACCINES IN HEALTHLY CHILDREN 12-15 MONTHS OF AGE

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/01 → 04/30/03

Funding

  • Merck and Company: $14,698.00